Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Levy

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Current Opinion in Critical Care|July 1, 2006
Lactate and shock state: the metabolic viewBruno Levy
Critical Care (London, England)|December 17, 2005
Bench-to-bedside review: Is there a place for epinephrine in septic shock?Bruno Levy
Critical Care Medicine|June 10, 2003
Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde?Bruno Levy
Lancet (London, England)|December 7, 2007
Use of pressors in the management of septic shockBruno Levy
Shock (Augusta, Ga.)|March 18, 2014
Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation: replyBruno Levy
Critical Care (London, England)|February 16, 2019
Predicting clinical outcome in patients undergoing VA-ECMOAntoine Kimmoun, Bruno Levy
Shock (Augusta, Ga.)|November 18, 2011
Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approachAntoine Kimmoun, Bruno Levy
Current Opinion in Critical Care|June 11, 2026
Pharmacological treatment of cardiogenic shockBruno Levy, Thomas Klein
Critical Care (London, England)|January 17, 2007
Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?Veronique Regnault, Bruno Levy
Critical Care (London, England)|February 4, 2015
Angiotensin II: a new approach for refractory shock management?Antoine Kimmoun, Bruno Levy
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Current Opinion in Critical Care|July 1, 2006
Lactate and shock state: the metabolic viewBruno Levy
Critical Care (London, England)|December 17, 2005
Bench-to-bedside review: Is there a place for epinephrine in septic shock?Bruno Levy
Critical Care Medicine|June 10, 2003
Epinephrine in septic shock: Dr. Jekyll or Mr. Hyde?Bruno Levy
Lancet (London, England)|December 7, 2007
Use of pressors in the management of septic shockBruno Levy
Shock (Augusta, Ga.)|March 18, 2014
Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation: replyBruno Levy
Critical Care (London, England)|February 16, 2019
Predicting clinical outcome in patients undergoing VA-ECMOAntoine Kimmoun, Bruno Levy
Shock (Augusta, Ga.)|November 18, 2011
Treatment of myocardial dysfunction in sepsis: the Toll-like receptor antagonist approachAntoine Kimmoun, Bruno Levy
Current Opinion in Critical Care|June 11, 2026
Pharmacological treatment of cardiogenic shockBruno Levy, Thomas Klein
Critical Care (London, England)|January 17, 2007
Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?Veronique Regnault, Bruno Levy
Critical Care (London, England)|February 4, 2015
Angiotensin II: a new approach for refractory shock management?Antoine Kimmoun, Bruno Levy
Pageof 23